Go to menu

SCIENTIFIC JOURNAL PUBLICATIONS

Publications

2018

Chhablnai J, Shaikh A, Goud A, Kawasaki R, Kwon OW, Chang A, Lam D, Das T,  Asia Pacific-Technology and Trend Survey 2016-17. Asia Pacific Journal of Ophthalmology (Accepted for publication)

Spooner K, Bahrami B, Hong T, Chang A. A Meta-Analysis of Patients with Treatment Resistant Macular Oedema Secondary to Retinal Vein Occlusions following Switching to Aflibercept. Acta Ophthalmologica (In press)

Bahrami B, Hong T, Schlub T, Chang A. Aflibercept for persistent diabetic macular edema: 48 week outcomes. Retina. (In press)

Ong PC, Te NA, Zagora S, Symes R, Yates Y, Chang A, McCluskey P, Simunovic M. Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora. Clinical & Experimental Ophthalmology  (In press)

Chow N, Hong T, Chang A. Multimodal imaging of macular subretinal deposits following intravitreal ocriplasmin injection. AJO Case Reports 2018 2018;9:80-84

2017

Chang A, Chan P, Schlottman. Latest developments in age-related macular degeneration. Asia Pac J Ophthalmol. 2017 [Epub ahead of print]

Bahrami B, Hong T, Gilles MC, Chang A. Anti-VEGF therapy for diabetic eye disease. Asia Pac J Ophthalmol (Phila). 2017 Oct 26. doi: 10.22608/APO.2017350. [Epub ahead of print]

Broadhead GK, Hong T, McCluskey P, Grigg JR, Schlub TE, Chang AA. Choroidal thickness and microperimetry sensitivity in age-related macular degeneration. Ophthalmic Res. 2017;58(1):27-34.

Bahrami B, Hong T, Zhu M, Sclubb T, Chang A. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1453-1454.

Chew J, Zhu M, Broadhead G, Luo K, Hong T, Chang A. Bilateral neovascular age-related macular degeneration: Comparisons between first and second eyes. Ophthalmologica. 2017;238(1-2):23-30.

Bahrami B, Ewe S, Hong T, Zhu M, Ong G, Luo K, Chang A. Influence of retinal pathology on the reliability of macular thickness measurement: a comparison between optical coherence tomography devices. Ophthalmic Surg Lasers Imaging Retina. 2017 Apr 1;48(4):319-325.

Nair R, Chang A. Challenges in the treatment of age-related macular degeneration. Medicine Today. 2017; 18(2): 400-400

Spooner K, Hong T, Wijeyakumar W, Chang AA. Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clinical Ophthalmology 2017,11:161-177

Bahrami B, Hong T, Zhu M, Schlub TE, Chang A. Switching therapy from bevacizumab to aflibercept for the management of persistent diabetic macular edema. Graefes Arch Clin Exp Ophthalmol. Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1133-1140

Zhu M Wijeyakumar W, Syed A, Joachim N, Hong T, Broadhead G, Li H, Luo K, Chang A, Vision-related quality of life: 12 month aflibercept treatment in patients with treatment-resistant neovascular age-related macular degeneration.  Graefes Arch Clin Exp Ophthalmol. 2017 Mar;255(3):475-484.

2016

Powner M, Sim D , Zhu M, Nobre-Cardoso J, Jones R, Syed A, Chang A , Keane P, Tufail A, Egan C. Evaluation of non-perfused retinal vessels in ischemic retinopathy. IOVS 2016, 1;57(11) 5031-5037

Bahrami B, Zhu M, Hong T, Chang A. Diabetic macular oedema: pathophysiology, management challenges and treatment resistance. Diabetologia 2016, 59(8): 1594-608

G K Broadhead J R Grigg P McCluskeyM KorsakovaA A Chang. Bevacizumab for choroidal neovascularisation in enhanced S-cone syndrome.Documenta Ophthalmologica 2016; 133(2): 139-143

Ewe S, Jamieson R, Chang A. Masquerade macular exudation in Mallatia Leventinese. Can J Ophthalmol 2016;51: e24–e27

Chang A, Broadhead G, Hong T, Joachim N, Syed A, Schlub T, Toth L, Peto T, Zhu M. Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes. Ophthalmic Research 2016;55: 84–90

2015

Chang A, Li H, Broadhead G, Luo K, Zhu M, Safety and Efficacy of Intravitreal Preservative-free Triamcinolone Acetonide (Triesence) for Macular Edema. Journal of Ocular Pharmacology and Therapeutics. 2015:31(9):563-9

Chang AA, Hong T, Ewe S, Badami B. The Role of Aflibercept in the management of Diabetic Macular Edema. Drug Design, Development and Therapy. 2015, 6:9:4389-96

Broadhead GK, Chang AA. Intravitreal aflibercept for choroidal neovascularization complicating chronic central serous retinopathy. Graefes Archive for clinical and experimental ophthalmology 2015; 253: 979-981

Broadhead GK, Grigg J, Chang AA, McCluskey P. Dietary Modification and Supplementation for the Treatment of Age-Related Macular Degeneration. Nutrition Reviews 2015; 73(7): 448-62

Staffieri SE, Rose L, Chang A, De Roach JN, McLaren TL, Mackey DA, Hewitt AW, Lamey TM. Clinical and molecular characterisation of females affected by X-linked retinoschisis. Clinical Experimental Ophthalmology 2015, 43(7):643-7

Broadhead GK, T Hong, Zhu M, Schulb T, Wijeyakumar W, Chang AA. Response of Pigment Epithelial Detachments to Intravitreal Aflibercept among Patients with Treatment-Resistant Neovascular Age-Related Macular Degeneration. Retina, 2015; 35(5): 975-81

2014

Zhu M, Chew J, Broadhead G, Luo K, Joachim N, Hong T, Syed A, Chang AA. Intravitreal Ranibizumab for neovascular age-related macular degeneration in clinical practice: 5 year treatment outcomes. Graefes Archive for clinical and experimental ophthalmology, 2014, 253(8).

Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, Zhu M. Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-related macular degeneration. Ophthalmology, 2014; 121(1): 188-192.

Broadhead G and Chang AA. Acetazolamide for Cystoid Macular Oedema in Bietti Crystalline Retinal Dystrophy. Korean J Ophthalmol 2014; 28(2):189-191.

Broadhead G, Hong T, Chang AA. Treating the Untreatable Patient: Current Options for the Management of Treatment-Resistant Neovascular Age-Related Macular Degeneration. Acta Ophthalmologica 2014; 92(8):713-23.

Broadhead G, Grigg J, Chang A, McCluskey P. Efficacy and Safety of Saffron Supplementation: Current Clinical Findings. Critical Reviews in Food Science and Nutrition. 2016, 9:56(16) 2767-76

Rush R, Simunovic M, Sheth S, Chang A Hunyor A. 23-Gauge Pars Plana Vitrectomy Versus Scleral Buckling Versus Combined Pars Plana Vitrectomy–Scleral Buckling for Medium-Complexity Retinal Detachment Repair. Asia-Pacific Journal of Ophthalmology 2014; 3: 215-219

2013

Chui J, Herkes G, Chang A. Management of fingolimod associated macular edema, JAMA Ophthalmology 2013; 131(5): 694-6

Broadhead G and Chang A. Choroidal Neovascularisation in Acquired Partial Lipodystrophy. European journal Ophthalmology 2013; 23(3): 439-41

Wang YD and Chang A. Clinical features and PDT effect of patients with CCSC. International Eye Science 2013. 13:3. 522-526

Chang A. Editorial. Is there one less hurdle for patients undergoing macular hole surgery? Asia-Pacific Journal of Ophthalmology 2013. 2(1):1-2

2012

Broadhead, GK, Chang, AA, and McCluskey, P, Genetics in Age-Related Macular Degeneration: Current Research and Implications for Future Treatment, Asia Pacific Journal Ophthalmology, 2012; 1(5): p. 312-18

Simunovic MP, Rush RP, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. British Journal Ophthalmology. 2012; 96 (6):862-6